Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Mediterranean Journal of Rheumatology|August 27, 2021
Biologic Therapies and Autoimmune PhenomenaAlexandros A Drosos, Eleftherios Pelechas, Evripidis Kaltsonoudis, et al.
Rheumatology (Oxford, England)|November 25, 2024
Pulmonary involvement in systemic sclerosis: can sex play a role?Nikolaos Koletsos, Evripidis Kaltsonoudis, Konstantinos Trentzidis, et al.
Joint Bone Spine|May 12, 2012
Fertility in male patients with seronegative spondyloarthropathies treated with infliximabIoanna Saougou, Theodora E Markatseli, Charalampos Papagoras, et al.
Arthritis Research & Therapy|June 19, 2014
Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological studyEvripidis Kaltsonoudis, Anastasia K Zikou, Paraskevi V Voulgari, et al.
Clinical Rheumatology|May 28, 2020
Correlation of patient preferences to treatment outcomes in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors in GreeceProdromos Sidiropoulos, Andreas Bounas, Panagiotis Athanassiou, et al.
Plos One|March 30, 2019
The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospitalEvripidis Kaltsonoudis, Eleftherios Pelechas, Alexandra Papoudou-Bai, et al.
Mediterranean Journal of Rheumatology|May 13, 2024
State of the Art Review on the Treatment of Psoriatic DiseaseEleftherios Pelechas, Evripidis Kaltsonoudis, Michalis P Migkos, et al.
Rheumatology International|March 3, 2021
Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experienceMichalis P Migkos, Evripidis Kaltsonoudis, Eleftherios Pelechas, et al.
Critical Reviews in Clinical Laboratory Sciences|November 12, 2021
Clinical features and diagnostic tools in idiopathic inflammatory myopathiesKonstantinos I Tsamis, Constantinos Boutsoras, Evripidis Kaltsonoudis, et al.
Clinical and Experimental Rheumatology|November 18, 2017
High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patientsKonstantinos Thomas, Irini Flouri, Argiro Repa, et al.
Pageof 4